HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryuji Tanosaki Selected Research

fludarabine

5/2005Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma.
7/2004Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryuji Tanosaki Research Topics

Disease

15Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2018 - 01/2004
12Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 03/2002
11Neoplasms (Cancer)
08/2021 - 01/2002
8Lymphoma (Lymphomas)
05/2015 - 01/2002
7Infections
01/2017 - 03/2002
6Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 04/2002
5Leukemia
03/2012 - 04/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 07/2007
4T-Cell Leukemia (Leukemia, T Cell)
04/2013 - 01/2004
3Melanoma (Melanoma, Malignant)
08/2021 - 01/2005
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2010 - 08/2007
2Thrombocytopenia (Thrombopenia)
05/2016 - 01/2004
2Neutropenia
10/2007 - 02/2002
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2007 - 05/2004
2Bronchiolitis Obliterans Syndrome
02/2005 - 06/2003
2Renal Cell Carcinoma (Grawitz Tumor)
07/2004 - 01/2004
1Ascites
03/2022
1Hypoalbuminemia
03/2022
1Postpartum Hemorrhage
09/2021
1Hemorrhage
09/2021
1Fever (Fevers)
08/2021
1Leukopenia
08/2021
1Transfusion Reaction
01/2021
1Vomiting
01/2020
1Nausea
01/2020
1Genetic Translocation (Chromosomal Translocation)
01/2017
1Lymphocytosis
01/2017
1Virus Diseases (Viral Diseases)
01/2016
1Mycoses (Diseases, Fungus)
01/2016
1Cytomegalovirus Infections (Inclusion Disease)
01/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2016
1Adenocarcinoma
09/2012
1Esophageal Squamous Cell Carcinoma
09/2012
1Adenocarcinoma of Lung
09/2012
1Papillary Carcinoma
09/2012
1Carcinoma (Carcinomatosis)
09/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2012
1Pathologic Complete Response
08/2012
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2012
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2012
1Gastritis
06/2010
1Inflammation (Inflammations)
05/2008
1Hyperglycemia
10/2007
1Plasma Cell Leukemia
09/2007
1Plasmacytoma
09/2007
1Large Granular Lymphocytic Leukemia
07/2007
1Body Weight (Weight, Body)
10/2006
1Diarrhea
10/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2006

Drug/Important Bio-Agent (IBA)

4SteroidsIBA
03/2022 - 03/2002
4VaccinesIBA
05/2015 - 06/2004
3Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2005
3HLA-A2 Antigen (HLA A2 Antigen)IBA
10/2012 - 01/2005
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
06/2008 - 04/2002
3Busulfan (Busulfex)FDA Link
05/2005 - 04/2002
2AlbuminsIBA
03/2022 - 10/2006
2AntigensIBA
01/2020 - 10/2012
2EpitopesIBA
04/2013 - 08/2005
2Monophenol Monooxygenase (Tyrosinase)IBA
10/2012 - 01/2005
2Peptides (Polypeptides)IBA
10/2012 - 01/2005
2thymoglobulinFDA Link
05/2005 - 07/2004
2fludarabineIBA
05/2005 - 07/2004
2CladribineFDA LinkGeneric
07/2004 - 04/2002
1ChemokinesIBA
08/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021
1CateninsIBA
08/2021
1Immune Checkpoint InhibitorsIBA
08/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2017
1eltrombopagFDA Link
05/2016
1Thrombopoietin ReceptorsIBA
05/2016
1GlucocorticoidsIBA
01/2016
1Prednisolone (Predate)FDA LinkGeneric
01/2016
1leucyl- leucyl- phenylalanyl- glycyl- tyrosyl- prolyl- valyl- tyrosyl- valineIBA
05/2015
1HLA-A24 AntigenIBA
10/2012
1Core Binding Factors (Core-Binding Factor)IBA
02/2009
1CytokinesIBA
05/2008
1C-Reactive ProteinIBA
05/2008
1Biomarkers (Surrogate Marker)IBA
05/2008
1Glucose (Dextrose)FDA LinkGeneric
10/2007
1Blood Glucose (Blood Sugar)IBA
10/2007
1HLA-A Antigens (HLA-A)IBA
08/2005
1Surface Antigens (Surface Antigen)IBA
07/2005

Therapy/Procedure

26Hematopoietic Stem Cell Transplantation
01/2018 - 11/2003
15Stem Cell Transplantation
01/2016 - 04/2002
12Transplantation
01/2018 - 07/2002
8Therapeutics
03/2022 - 03/2002
7Cell Transplantation
01/2018 - 08/2007
6Immunotherapy
10/2012 - 06/2004
3Blood Transfusion (Blood Transfusions)
09/2021 - 11/2003
3Drug Therapy (Chemotherapy)
01/2014 - 01/2004
1Hysterectomy
09/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2021
1ACT regimen
08/2021
1Aftercare (After-Treatment)
01/2016
1Lasers (Laser)
09/2012
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
09/2012
1Hematopoietic Stem Cell Mobilization
12/2011
1Investigational Therapies (Experimental Therapy)
12/2011
1Parenteral Nutrition
10/2007
1Nutritional Support (Artificial Feeding)
10/2006